The most common adverse events and median CD4 at time of event were rash ( 15.2 % ; CD4 , 285 cells/microL ) and peripheral neuropathy ( 9.0 % and 348 cells/microL ) .
O O O O O O O B-GeneOrGeneProduct O O O O O B-DiseaseOrPhenotypicFeature O O O O B-GeneOrGeneProduct O O O O O B-DiseaseOrPhenotypicFeature I-DiseaseOrPhenotypicFeature O O O O O O O O